Dr. Shahinfar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24 springton pointe drive, Newtown Square, pa
East Mc Keesport, PA 19073Phone+1 610-209-0004
Certifications & Licensure
PA State Medical License 1981 - 2016- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- 34 citationsEfficacy and safety of losartan in children with Alport syndrome—results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trialNicholas J. A. Webb, Chun Lam, Shahnaz Shahinfar, Juergen Strehlau, Thomas G. Wells
Nephrology, Dialysis, Transplantation. 2011-08-01 - 5173 citationsEFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHYBarry M. Brenner, Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch
The New England Journal of Medicine. 2001-09-20 - 59 citationsACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.Hans-Henrik Parving, Dick de Zeeuw, Mark E. Cooper, Giuseppe Remuzzi, Nancy Liu
Journal of the American Society of Nephrology. 2008-04-01
Authored Content
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy — NEJMSeptember 2001
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
